AmSurg insiders looking to sell

Email | Print By Richard Daverman

08-08-2001 12:00 AM — Numerous Amsurg Corp. (AMSG) officers have proposed selling large blocks of company stock following a strong advance in share price the past year, according to recent SEC filings. The proposed sellers are:

* David L. Manning, senior vice president, planning to sell 140,000 shares for proceeds of roughly $3.9 million.

* Rodney H. Lunn, the head of center operations who recently left the company, selling 52,000 shares for proceeds of $1.43 million.

* Royce D. Harrell, senior vice president, selling 50,000 shares for $1.38 million.

* Claire M. Gulmi, chief financial officer, selling 23,332 shares for $641,630.

* Bergein Overholt, a director, selling 35,000 shares for $837,200.

* James A. Deal, a director, selling 25,000 shares for $660,750.

The stock has performed very well lately. Earlier this month it hit an all-time high of $30 per share. Wednesday morning it was trading at $27.90; prior to last September, the stock was changing hands below $8.

On April 6 of this year, the company priced a 4 million share offering at $18 per share. In that offering, Chairman Tom Cigarran and director Henry Herr sold a total of 74,000 shares, with the company selling the rest.

In June, Fortune Small Business Magazine named AmSurg number 12 in its list of 100 fastest growing publicly held small companies, based on earnings growth, revenue growth and stock appreciation. The company has a price-earnings ratio of 41, based on the last 12 month’s earnings.